Bridging Therapy With Tenecteplase or Al...

In part one of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the fenebrutinib trial and highlight the key takeaways that healthcare providers should be aware of. For more information, please read about the abstract that was presented at the 2026 A ... Show More

In part one of this series, Dr. Halley Alexander and Dr. Heidi Munger Clary discuss the best methods for screening patients with epilepsy in a clinical setting. Show citations: Mula M, Brodie MJ, de Toffol B, et al. ILAE clinical practice recommendations for the medical treatment ... Show More

In the second episode of this series, Dr. Dara Albert and Dr. Jon Stone discuss the future of FND and the innovative topics presented at the conference. 

Dr. Dan Ackerman talks with Dr. Thanh Nguyen about whether dual antiplatelet therapy is noninferior to intravenous thrombolysis among patients with minor nondisabling acute ischemic stroke. Read the related article in JAMA. Visit NPUb.org/Podcast for associated article links. Thi ... Show More

Dr. Dan Ackerman talks with Dr. Silja Räty about the outcomes of patients with basilar artery occlusion treated with intravenous thrombolysis (IVT) only and compares IVT with endovascular thrombectomy. Read the related article in Neurology. This podcast is sponsored by argenx. Vi ... Show More

Dr. Dan Ackerman talks with Dr. Andy Southerland about the impact of glucose control on the risk of symptomatic intracerebral hemorrhage following thrombolysis for acute ischemic stroke. Read the related article in Neurology.  This podcast is sponsored by argenx. Visit www.vyvgar ... Show More

Dr. Dan Ackerman talks with Dr. Luciano A. Sposato about the topic of embolic stroke of undetermined source and the controversies surrounding cardiac monitoring and anticoagulation.  Read the related article in Neurology.  Disclosures can be found at Neurology.org. 

<p><span data-sheets-value= "{"1":2,"2":".Dr. Andrew Southerland talks with Drs. Hassan Kobeissi and Alejandro Rabinstein about Lit review of studies looking at late window (6-24hrs) endovascular intervention who had either CT perfusion vs non-con head CT found that functional in ... Show More

Dr. Venu Menon, Director of the Cardiovascular Fellowship Program and Section Head, Clinical Cardiology and Chetan Huded MD, Interventional Fellow discuss incidence of stroke up to 30 days after TAVR. Dr. Huded published his findings in JAMA . Drs. Menon and Huded discuss the pat ... Show More

Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent trials presented at the European Stroke Organization Conference. Show references:  Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy  Rationale and Design of Tenecteplase Reperfusion Therap ... Show More

N Engl J Med 1993;328:673-679Background: Previous trials established that thrombolysis improves mortality in patients with acute myocardial infarction, as seen in the GISSI-1 and ISIS-2 trials. However, thrombolysis has limitations, including an increased risk of bleeding and the ... Show More